HIT and the Transformation of Clinical Research

Loading... Loading video...

Air date:	Thursday, July 16, 2009, 10:00:00 AM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 88 * This only includes stats from October 2011 and forward.
Category:	Special
Runtime:	01:22:24
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	The ARRA provides for a significant investment in health information technology (HIT) for the US. One of the required features of this investment is the ability for meaningful health information exchange between providers. While many have postulated the potential benefits of HIT over the last several years, there is still controversy about the use of this technology. However, with ARRA, the commitment to transformation of this sector is clear. In assessing the benefits of HIT, one of the exciting applications is to transform clinical research, especially for lifestyle or behavior studies. In this talk, we'll review the potential benefits of HIT overall and in the clinical research setting, including the concept of personal health records. We’ll then explore a novel study design enabled by HIT that has compelling economic and scientific advantages. The risks and benefits of this approach will be examined. Seminar to be given by Dr. Kevin Schulman, M.D. Professor of Medicine at Duke University Director, Center for Clinical and Genetic Economics

NLM Title:	HIT and the transformation of clinical research / Kevin Schulman.
Author:	Schulman, Kevin. National Institutes of Health (U.S.)
Publisher:
Abstract:	(CIT): The ARRA provides for a significant investment in health information technology (HIT) for the US. One of the required features of this investment is the ability for meaningful health information exchange between providers. While many have postulated the potential benefits of HIT over the last several years, there is still controversy about the use of this technology. However, with ARRA, the commitment to transformation of this sector is clear. In assessing the benefits of HIT, one of the exciting applications is to transform clinical research, especially for lifestyle or behavior studies. In this talk, we'll review the potential benefits of HIT overall and in the clinical research setting, including the concept of personal health records. We"ll then explore a novel study design enabled by HIT that has compelling economic and scientific advantages. The risks and benefits of this approach will be examined. Seminar to be given by Dr. Kevin Schulman, M.D. Professor of Medicine at Duke University Director, Center for Clinical and Genetic Economics.
Subjects:	Clinical Trials as Topic--economics Diet Internet Obesity
Publication Types:	Lecture Webcast
NLM Classification:	WD 210
NLM ID:	101512274
CIT Live ID:	7800
Permanent link:	https://videocast.nih.gov/watch=7800

NIH VideoCasting